Skip to main navigation Skip to search Skip to main content

Challenges in studying microplastics in human brain

  • Fazel A. Monikh*
  • , Dušan Materić
  • , Eugenia Valsami-Jones
  • , Hans-Peter Grossart
  • , Korinna Altmann
  • , Rupert Holzinger
  • , Iseult Lynch
  • , Jessica Stubenrauch
  • , Willie Peijnenburg
  • *Corresponding author for this work

Research output: Contribution to journal › Comment/debate

79 Downloads (Pure)

Abstract

Human exposure to microplastics and nanoplastics (MNPs) is an emerging concern with potential implications for health. As awareness of this issue grows, it has prompted increasing scientific attention toward understanding if, and how, MNPs accumulate in human tissues. In a recent study, Nihart et al.1 used the analytical technique of pyrolysis gas chromatography–mass spectrometry (Py-GC–MS) to detect MNPs in human liver, kidney and brain, reporting the highest concentrations in the brain, with polyethylene as the predominant polymer. The study as reported appears to face methodological challenges, such as limited contamination controls and lack of validation steps, which may affect the reliability of the reported concentrations. In this Matters Arising, we highlight methodological limitations that have general relevance for advancing robust and reproducible MNP detection in human biomonitoring studies.
Original languageEnglish
Number of pages3
JournalNature Medicine
Early online date13 Nov 2025
DOIs
Publication statusE-pub ahead of print - 13 Nov 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Challenges in studying microplastics in human brain'. Together they form a unique fingerprint.

Cite this